Abbott Laboratories (Pakistan) Limited (PSX:ABOT)
1,179.85
-11.19 (-0.94%)
At close: Sep 4, 2025
PSX:ABOT Revenue
Abbott Laboratories (Pakistan) had revenue of 19.06B PKR in the quarter ending June 30, 2025, with 17.88% growth. This brings the company's revenue in the last twelve months to 72.39B, up 19.78% year-over-year. In the year 2024, Abbott Laboratories (Pakistan) had annual revenue of 68.18B with 22.90% growth.
Revenue (ttm)
72.39B
Revenue Growth
+19.78%
P/S Ratio
1.61
Revenue / Employee
51.48M
Employees
1,406
Market Cap
116.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 68.18B | 12.70B | 22.90% |
Dec 31, 2023 | 55.48B | 6.22B | 12.62% |
Dec 31, 2022 | 49.26B | 6.69B | 15.71% |
Dec 31, 2021 | 42.57B | 7.29B | 20.65% |
Dec 31, 2020 | 35.28B | 5.13B | 17.00% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
GlaxoSmithKline Pakistan | 62.62B |
Highnoon Laboratories | 25.78B |
The Searle Company | 29.12B |
AGP Limited | 26.11B |
Shifa International Hospitals | 26.63B |
Citi Pharma | 12.97B |
Ferozsons Laboratories | 18.16B |
Macter International | 8.48B |